MyJournals Home  

RSS FeedsGilead injects own generics into shrinking HCV drug market (Nature Biotechnology)

 
 

10 november 2018 12:00:02

 
Gilead injects own generics into shrinking HCV drug market (Nature Biotechnology)
 




 
94 viewsCategory: Biotechnology
 
An avatar for precision cancer therapy (Nature Biotechnology)
Q3 2018--The beat goes on (Nature Biotechnology)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Biotechnology


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten